drugset / Trial / NCT01881737

A Study of Pregnenolone in the Treatment of Individuals With Autism

NCT01881737

Phase 2 Completed 15 enrolled Stanford University
NaSingle-groupOpen-labelTreatment

Summary

This study will assess the tolerability and effectiveness of pregnenolone in the treatment of behavioral deficits in adults with autism. Pregnenolone is a naturally occurring hormone found in the body which has been shown to help with the function of nerve cells. It is also shown to modulate the activity of certain brain receptors implicated in autism. We hope to examine the tolerability of pregnenolone in adults with autism.

Timeline

Start
2011-07
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregnenolone Other / unclassified 500 mg Oral

Indications